Tuberculosis Screening Options Pros and Cons
Sponsored Content
Listen to our Podcast on A Personal Perspective on TB Screening
Listen to our Podcast on Making Sense of TB Testing Guidelines
Listen to our Podcast on Tuberculosis Screening 101: A Primer
Download our Supplement on Importance of Screening for Tuberculosis Infection in the Ob/Gyn Community
Amita Gupta, MD, MHS, discusses the efficacy and limitations of screening options, including the protein purified derivative (PPD) test, and interferon gamma release assays using either a chemiluminescence automated platform or an enzyme-linked immunospot assay.
Presented by: Amita Gupta, MD MHS
Deputy Director of Center for Clinical Global Health Education, Professor of Infectious Diseases
School of Medicine and Bloomberg School of Public Health
Dr. Amita Gupta is Deputy Director of the Johns Hopkins (JH) Center for Clinical Global Health Education (CCGHE), and Professor of Infectious Diseases at the JH School of Medicine, with a joint appointment in International Health at the JH Bloomberg School of Public Health.
